Thrombolytic therapy in venous occlusive disease.
Dake
M D
MD
Division of Cardiovascular and Interventional Radiology, Stanford University Medical Center, CA 94305, USA.
Semba
C P
CP
D000328:Adult; D000368:Aged; D000800:Angioplasty, Balloon / Q000295:instrumentation; D003131:Combined Modality Therapy; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004867:Equipment Design; D005260:Female; D005343:Fibrinolytic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D010690:Phlebography / Q000295:instrumentation; D015607:Stents; D015912:Thrombolytic Therapy / Q000295:instrumentation; D013924:Thrombophlebitis / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000209:etiology; D014568:Urokinase-Type Plasminogen Activator / Q000008:administration & dosage* / Q000009:adverse effects
D005343:Fibrinolytic Agents; D014568:Urokinase-Type Plasminogen Activator